Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imovax Rabies and Verorab pre-exposure and simulated post-exposure prophylaxis study
2020-001223-14Phase 3
- Sponsor
- Sanofi
- Start
- Nov 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of rabies virus inactivated antigen, B and rabies virus inactivated antigen, A in rabies (3 arms), sponsored by Sanofi. Primary endpoint: Seroconversion of participant.
02
Drugs
rabies virus inactivated antigen, Brabies virus inactivated antigen, A
03
Conditions
rabies
Beyond the preview
Go deeper on 2020-001223-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001223-14.